Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Yuan Luo, Rensheng Song, Yi-Yun Ma, Dawei Tang, Xu-Chen Liu, Qi-Hui Tang, Xiao-Fu Zhuang, Juan Zhou, Jun-Xiong Lu, Zhizhong Wang, Xue-Yan Jiang, Gen He
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study
10.1016/j.jacc.2020.11.010 · 2020
Mortality from ischemic heart disease: analysis of data from the World Health Organization and coronary artery disease risk factors from NCD Risk Factor Collaboration
2019
Advanced cardiac patches for the treatment of myocardial infarction
10.1161/circulationaha.123.067097 · 2024
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
10.1038/s41569-020-0403-y · 2020
The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis
10.1161/circresaha.116.303577 · 2016
The inflammatory response in myocardial injury, repair, and remodelling
10.1038/nrcardio.2014.28 · 2014
Spatial multi-omic map of human myocardial infarction
10.1038/s41586-022-05060-x · 2022
Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury
10.1152/ajpheart.00158.2018 · 2018
Signaling pathways and targeted therapy for myocardial infarction
10.1038/s41392-022-00925-z · 2022
The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
10.1038/s41569-023-00946-3 · 2024
The NLRP3 inflammasome in acute myocardial infarction
10.1038/nrcardio.2017.161 · 2018
Targeting the NLRP3 inflammasome in inflammatory diseases
10.1038/nrd.2018.97 · 2018
Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities
10.1016/j.pharmthera.2018.01.001 · 2018
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
10.1038/nm.3806 · 2015
The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction
2017
MCC950 closes the active conformation of NLRP3 to an inactive state
10.1038/s41589-019-0278-6 · 2019
Activation of the macrophage-associated inflammasome exacerbates myocardial fibrosis through the 15-HETE-mediated pathway in acute myocardial infarction
10.1016/j.eng.2024.05.015 · 2024
Spatiotemporal signaling underlies progressive vascular rarefaction in myocardial infarction
10.1038/s41467-023-44227-6 · 2023
Protein therapeutics for cardiac regeneration after myocardial infarction
10.1007/s12265-010-9207-5 · 2010
MMP 9-instructed assembly of bFGF nanofibers in ischemic myocardium to promote heart repair
10.7150/thno.77345 · 2022
Injection of ROS‐responsive hydrogel loaded with basic fibroblast growth factor into the pericardial cavity for heart repair
2021
Hydrogel‐based growth factor delivery platforms: strategies and recent advances
10.1002/adma.202210707 · 2024
An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction
10.1016/j.jconrel.2023.10.056 · 2024
Injectable hydrogels with tailored recombinant humanized collagen type I for the repair of damaged hearts by remodeling the myocardial microenvironment
10.1186/s42825-025-00212-x · 2025
The application of nanomedicines in repairing damage in myocardial infarction
10.1016/j.jconrel.2025.114388 · 2025
Microneedle-mediated gene delivery for the treatment of ischemic myocardial disease
10.1126/sciadv.aaz3621 · 2020
Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model
10.1161/circulationaha.106.662577 · 2007
Bifunctional peptide amphiphile hydrogel orchestrates concerted antioxidant and anti‐inflammatory actions to counter myocardial Ischemia/Reperfusion Injury
2026
One endothelium-targeted combined nucleic acid delivery system for myocardial infarction therapy
10.1021/acsnano.3c11661 · 2024
Flexible polymeric patch based nanotherapeutics against non-cancer therapy
2022
Microneedle patch loaded with exosomes containing microRNA‐29b prevents cardiac fibrosis after myocardial infarction
2023
Microneedle stent for intravascular anchoring effect
2026
Microneedles at the forefront of next generation theranostics
10.1002/advs.202412140 · 2025
Differential dual‐release bilayer microneedles loaded with aluminum adjuvants as a safe and effective vaccine platform
10.1002/adfm.202201952 · 2022
Double-layered core-shell microneedle patch integrated with microparticles for long-acting treatment of osteoporosis
10.1016/j.jconrel.2025.113898 · 2025
Highly efficient intrastromal dual-drug delivery by a dissolving bilayer microneedle for synergistic therapy against corneal neovascularization
10.1021/acsnano.5c10610 · 2025
Spatiotemporal immunomodulation of macrophages via NLRP3/IL‐1β pathway by Core‐Shell microneedles to promote healing of biofilm‐infected diabetic ulcers
10.1002/smll.202505179 · 2025
Minimally invasive snakebite inspired microneedle delivery system for internal organs
2025
Chiral D-peptide composite hydrogels enable sustained RepSox delivery and antifibrotic remodeling after myocardial infarction
10.1016/j.biomaterials.2026.124343 · 2026
Hydrogel crosslinked by chiral bioactive peptides for synergistic oxidative stress scavenging and targeted anti‐fibrotic therapy after myocardial infarction
10.1002/adfm.76154 · 2026
Self‐oxygenating PROTAC microneedle for spatiotemporally‐confined protein degradation and enhanced glioblastoma therapy
10.1002/adma.202411869 · doi-reference
Hierarchical double-layer microneedles accomplish multicenter skin regeneration in diabetic full-thickness wounds
10.1016/j.jare.2024.01.002 · doi-reference
Microneedles-based theranostic platform: from the past to the future
10.1021/acsnano.4c04277 · doi-reference
Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction
10.1016/j.jacc.2016.01.073 · doi-reference
Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury
10.7150/thno.48436 · doi-reference
Light-activated gold–selenium core–shell nanocomposites with NIR-II photoacoustic imaging performances for heart-targeted repair
10.1021/acsnano.2c07311 · doi-reference
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
10.1093/cvr/cvt091 · doi-reference
Inflammation in acute myocardial infarction: the good, the bad and the ugly
10.1093/eurheartj/ehad486 · doi-reference
Extracellular matrix/glycopeptide hybrid hydrogel as an immunomodulatory niche for endogenous cardiac repair after myocardial infarction
10.1002/advs.202301244 · doi-reference